{"ticker": {"uuid": "3b0b41b8-246b-4238-9e82-a53e88ebdba4", "symbol": "I1NC34", "name": "Incyte Corporation", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "WILMINGTON, Del., August 07, 2026--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it granted restricted stock unit awards (RSUs) representing an aggregate of 21,556 shares of the Company's common stock and stock option awards to purchase an aggregate of 18,172 shares of the Company's common stock to 24 new employees. The awards were made under the Company's 2024 Inducement Stock Incentive Plan, with a grant date and vesting commencement date of August 3, 2026, and were approved by the compensation committee of the Company's board of directors as an inducement material ", "url": "https://finance.yahoo.com/markets/stocks/articles/incyte-reports-inducement-grants-under-203000999.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T20:30:00+00:00", "published_display": "07 Aug 2026 20:30", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.097, "duplicate_count": 1, "topics": ["Biopharmaceuticals", "Oncology", "Stock Awards"]}], "by_tier": {"direct": [{"title": "Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "WILMINGTON, Del., August 07, 2026--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it granted restricted stock unit awards (RSUs) representing an aggregate of 21,556 shares of the Company's common stock and stock option awards to purchase an aggregate of 18,172 shares of the Company's common stock to 24 new employees. The awards were made under the Company's 2024 Inducement Stock Incentive Plan, with a grant date and vesting commencement date of August 3, 2026, and were approved by the compensation committee of the Company's board of directors as an inducement material ", "url": "https://finance.yahoo.com/markets/stocks/articles/incyte-reports-inducement-grants-under-203000999.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T20:30:00+00:00", "published_display": "07 Aug 2026 20:30", "provider": "eodhd", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.097, "duplicate_count": 1, "topics": ["Biopharmaceuticals", "Oncology", "Stock Awards"]}], "industry": [], "sector": []}, "total_fetched": 1, "total_unique": 1, "total_relevant": 1, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 1}, "raw_articles": 1, "unique_stories": 1, "duplicates_removed": 0, "relevant_stories": 1, "current_evidence": 1, "direct_evidence": 1, "eodhd_articles": 1, "eodhd": {"configured": true, "status": "healthy", "calls_used": 250, "call_budget": 500, "budget_used_pct": 50.0, "requests_made": 50, "last_success_at": "2026-08-13T08:15:28.497200+00:00", "newest_seen_at": "2026-08-13T08:00:00+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3313, "unmapped_mentions": 1843}, "status": "healthy"}, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 0, "score": 54, "raw_score": 61, "total": 1, "evidence_count": 1, "effective_articles": 1.0, "direct_story_count": 1, "industry_story_count": 0, "sector_story_count": 0, "story_count": 1, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 0, "confidence": 38, "evidence_status": "measured", "score_version": "evidence-v4", "newest_article_at": "2026-08-07T20:30:00+00:00", "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 72, "events": [{"event": "general", "label": "Market update", "weight": 0.6, "count": 1}], "positive_events": 1, "negative_events": 0, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 1}, "raw_articles": 1, "unique_stories": 1, "duplicates_removed": 0, "relevant_stories": 1, "current_evidence": 1, "direct_evidence": 1, "eodhd_articles": 1, "eodhd": {"configured": true, "status": "healthy", "calls_used": 250, "call_budget": 500, "budget_used_pct": 50.0, "requests_made": 50, "last_success_at": "2026-08-13T08:15:28.497200+00:00", "newest_seen_at": "2026-08-13T08:00:00+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3313, "unmapped_mentions": 1843}, "status": "healthy"}}, "market_context": {"has_market_context": true, "latest_close": 306.9, "latest_week": "2026-08-07", "one_week_move": 4.0, "four_week_move": 2.2, "twelve_week_move": 28.5, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.060404, "market_dynamics_buy_signal": false, "relative_strength": 14.09271, "fair_value_gap": 49.4, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 25.4132, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.0% over one week, +2.2% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 48, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 1}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Evidence confidence", "value": "38/100", "tone": "neutral", "text": "1.0 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "72/100 classification confidence."}, {"label": "Company focus", "value": "1", "tone": "neutral", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "0/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+4.0% over one week, +2.2% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)"}], "updated_at": "2026-08-13T08:16:29.705636+00:00", "detail_intelligence": {"headline": "Price moving ahead of tone", "summary": "Balanced news tone is drawn from 1 fresh independent stories, including 1 company-specific items across 1 publishers.", "status": "measured", "metrics": [{"label": "Weighted tone", "value": 54, "display": "54", "tone": "neutral", "note": "Balanced news tone"}, {"label": "Evidence confidence", "value": 38, "display": "38", "tone": "neutral", "note": "thin evidence"}, {"label": "Company focus", "value": 100, "display": "100%", "tone": "positive", "note": "1 direct stories"}, {"label": "Evidence agreement", "value": 0, "display": "N/A", "tone": "neutral", "note": "requires at least 2 stories"}], "confidence_drivers": [{"label": "Sample depth", "value": 12, "note": "1.0 effective stories"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Direct relevance", "value": 100, "note": "company-specific evidence share"}, {"label": "Freshness", "value": 39, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 0, "note": "requires at least 2 stories"}, {"label": "Source independence", "value": 0, "note": "lower publisher concentration"}], "freshness": 39, "source_independence": 0, "timeline": [{"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 87.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 133.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 179.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 225.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 271.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 316.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 362.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 408.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 454.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 500.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 545.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 591.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 637.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 1, "score": 61, "tone": "positive", "x": 683.2, "y": 115.0, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 729.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 774.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 0, "score": null, "tone": "neutral", "x": 820.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 0, "score": null, "tone": "neutral", "x": 866.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 0, "score": null, "tone": "neutral", "x": 912.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "683.2,115.0", "timeline_has_signal": true, "timeline_start": "24 Jul", "timeline_mid": "03 Aug", "timeline_end": "13 Aug", "momentum": {"label": "Cooling", "tone": "neutral", "recent_score": null, "prior_score": 61, "delta": null, "recent_count": 0, "prior_count": 1, "volume_delta": -1}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 0, "share": 0}, {"label": "4 to 7 days", "count": 1, "share": 100}, {"label": "8 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 1, "share": 100, "score": 61, "tone": "positive"}], "event_profile": [{"label": "Market update", "count": 1, "share": 100, "score": 61, "tone": "positive"}], "topics": [{"label": "Stock Awards", "count": 1, "share": 100}, {"label": "Oncology", "count": 1, "share": 100}, {"label": "Biopharmaceuticals", "count": 1, "share": 100}], "supporting": [{"label": "Direct evidence", "text": "1 current stories are mapped specifically to I1NC34."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}, {"label": "Price disagreement", "text": "Price is moving more forcefully than the current news tone suggests."}], "supporting_heading": "What supports the read", "tempering_heading": "What tempers the read", "latest_observation": {"title": "Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)", "summary": "WILMINGTON, Del., August 07, 2026--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) announced today that it granted restricted stock unit awards (RSUs) representing an aggregate of 21,556 shares of the Company's common stock and stock option awards to purchase an aggregate of 18,172 shares of the Company's common stock to 24 new employees. The awards were made under the Company's 2024 Inducement Stock Incentive Plan, with a grant date and vesting commencement date of August 3, 2026, and were approved by the compensation committee of the Company's board of directors as an inducement material ", "url": "https://finance.yahoo.com/markets/stocks/articles/incyte-reports-inducement-grants-under-203000999.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-07T20:30:00+00:00", "published_display": "07 Aug 2026 20:30", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.097, "duplicate_count": 1, "topics": ["Biopharmaceuticals", "Oncology", "Stock Awards"]}, "article_count": 1, "updated_at": "2026-08-13T08:16:29.705636+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 138.7, "label": "13 Feb 2026", "close": 267.36, "index": 100.0}, {"x": 78.6, "y": 153.0, "label": "20 Feb 2026", "close": 260.55, "index": 97.5}, {"x": 115.2, "y": 165.2, "label": "27 Feb 2026", "close": 254.75, "index": 95.3}, {"x": 151.9, "y": 172.2, "label": "06 Mar 2026", "close": 251.42, "index": 94.0}, {"x": 188.5, "y": 179.4, "label": "13 Mar 2026", "close": 248.0, "index": 92.8}, {"x": 225.1, "y": 190.9, "label": "20 Mar 2026", "close": 242.5, "index": 90.7}, {"x": 261.7, "y": 198.7, "label": "27 Mar 2026", "close": 238.8, "index": 89.3}, {"x": 298.4, "y": 192.5, "label": "03 Apr 2026", "close": 241.75, "index": 90.4}, {"x": 335.0, "y": 187.2, "label": "10 Apr 2026", "close": 244.25, "index": 91.4}, {"x": 371.6, "y": 192.2, "label": "17 Apr 2026", "close": 241.88, "index": 90.5}, {"x": 408.2, "y": 204.2, "label": "24 Apr 2026", "close": 236.16, "index": 88.3}, {"x": 444.9, "y": 181.0, "label": "01 May 2026", "close": 247.2, "index": 92.5}, {"x": 481.5, "y": 195.1, "label": "08 May 2026", "close": 240.48, "index": 89.9}, {"x": 518.1, "y": 198.5, "label": "15 May 2026", "close": 238.88, "index": 89.3}, {"x": 554.7, "y": 194.6, "label": "22 May 2026", "close": 240.72, "index": 90.0}, {"x": 591.3, "y": 187.7, "label": "29 May 2026", "close": 244.0, "index": 91.3}, {"x": 628.0, "y": 200.2, "label": "05 Jun 2026", "close": 238.08, "index": 89.0}, {"x": 664.6, "y": 128.1, "label": "12 Jun 2026", "close": 272.44, "index": 101.9}, {"x": 701.2, "y": 167.8, "label": "19 Jun 2026", "close": 253.5, "index": 94.8}, {"x": 737.8, "y": 87.0, "label": "26 Jun 2026", "close": 292.04, "index": 109.2}, {"x": 774.5, "y": 76.7, "label": "03 Jul 2026", "close": 296.96, "index": 111.1}, {"x": 811.1, "y": 69.7, "label": "10 Jul 2026", "close": 300.3, "index": 112.3}, {"x": 847.7, "y": 69.7, "label": "17 Jul 2026", "close": 300.3, "index": 112.3}, {"x": 884.3, "y": 80.8, "label": "24 Jul 2026", "close": 295.0, "index": 110.3}, {"x": 920.9, "y": 80.8, "label": "31 Jul 2026", "close": 295.0, "index": 110.3}, {"x": 957.6, "y": 55.8, "label": "07 Aug 2026", "close": 306.9, "index": 114.8}], "sentiment_points": [{"x": 710.9, "y": 119.0, "label": "20 Jun 2026", "score": 56}, {"x": 712.3, "y": 119.0, "label": "21 Jun 2026", "score": 56}, {"x": 716.2, "y": 119.0, "label": "21 Jun 2026", "score": 56}, {"x": 717.8, "y": 120.8, "label": "22 Jun 2026", "score": 55}, {"x": 718.9, "y": 120.8, "label": "22 Jun 2026", "score": 55}, {"x": 719.4, "y": 120.8, "label": "22 Jun 2026", "score": 55}, {"x": 721.2, "y": 124.5, "label": "22 Jun 2026", "score": 53}, {"x": 721.5, "y": 122.6, "label": "22 Jun 2026", "score": 54}, {"x": 739.1, "y": 119.0, "label": "26 Jun 2026", "score": 56}, {"x": 748.5, "y": 120.8, "label": "28 Jun 2026", "score": 55}, {"x": 763.4, "y": 120.8, "label": "30 Jun 2026", "score": 55}, {"x": 772.3, "y": 122.6, "label": "02 Jul 2026", "score": 54}, {"x": 772.9, "y": 122.6, "label": "02 Jul 2026", "score": 54}, {"x": 778.7, "y": 124.5, "label": "03 Jul 2026", "score": 53}, {"x": 780.3, "y": 124.5, "label": "04 Jul 2026", "score": 53}, {"x": 798.0, "y": 124.5, "label": "07 Jul 2026", "score": 53}, {"x": 802.8, "y": 122.6, "label": "08 Jul 2026", "score": 54}, {"x": 833.8, "y": 126.3, "label": "14 Jul 2026", "score": 52}, {"x": 839.7, "y": 124.5, "label": "15 Jul 2026", "score": 53}, {"x": 841.7, "y": 130.0, "label": "15 Jul 2026", "score": 50}, {"x": 844.7, "y": 130.0, "label": "16 Jul 2026", "score": 50}, {"x": 858.4, "y": 126.3, "label": "19 Jul 2026", "score": 52}, {"x": 874.9, "y": 126.3, "label": "22 Jul 2026", "score": 52}, {"x": 877.5, "y": 130.0, "label": "22 Jul 2026", "score": 50}, {"x": 881.7, "y": 124.5, "label": "23 Jul 2026", "score": 53}, {"x": 881.9, "y": 124.5, "label": "23 Jul 2026", "score": 53}, {"x": 907.7, "y": 120.8, "label": "28 Jul 2026", "score": 55}, {"x": 931.6, "y": 120.8, "label": "02 Aug 2026", "score": 55}, {"x": 935.3, "y": 117.1, "label": "02 Aug 2026", "score": 57}, {"x": 944.4, "y": 119.0, "label": "04 Aug 2026", "score": 56}, {"x": 958.0, "y": 117.1, "label": "07 Aug 2026", "score": 57}], "price_path": "42.0,138.7 78.6,153.0 115.2,165.2 151.9,172.2 188.5,179.4 225.1,190.9 261.7,198.7 298.4,192.5 335.0,187.2 371.6,192.2 408.2,204.2 444.9,181.0 481.5,195.1 518.1,198.5 554.7,194.6 591.3,187.7 628.0,200.2 664.6,128.1 701.2,167.8 737.8,87.0 774.5,76.7 811.1,69.7 847.7,69.7 884.3,80.8 920.9,80.8 957.6,55.8", "sentiment_path": "710.9,119.0 712.3,119.0 716.2,119.0 717.8,120.8 718.9,120.8 719.4,120.8 721.2,124.5 721.5,122.6 739.1,119.0 748.5,120.8 763.4,120.8 772.3,122.6 772.9,122.6 778.7,124.5 780.3,124.5 798.0,124.5 802.8,122.6 833.8,126.3 839.7,124.5 841.7,130.0 844.7,130.0 858.4,126.3 874.9,126.3 877.5,130.0 881.7,124.5 881.9,124.5 907.7,120.8 931.6,120.8 935.3,117.1 944.4,119.0 958.0,117.1", "price_change": 14.8, "sentiment_change": 1, "latest_close": 306.9, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug"}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}